[1]	Yano S, Zhang Y, Miwa S, et al. Spatial-temporal FUCCI imaging of each cell in a tumor demonstrates locational dependence of cell cycle dynamics and chemoresponsiveness[J]. Cell Cycle, 2014, 13(13):2110-2119.DOI:10.4161/cc.29156.

[2]	Li X, Cao G, Liu X, et al. Polymerases and DNA repair in neurons:implications in neuronal survival and neurodegenerative diseases[J]. Front Cell Neurosci, 2022,16:852002.DOI:10.3389/fncel.2022.852002.

[3]	Liu DZ, Ander BP. Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases:an update[J]. Sci World J, 2012,2012:491737.DOI:10.1100/2012/491737. Cited in this article [1]

[4]	Lee RC, Feinbaum RL, Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14[J]. Cell, 1993, 75(5):843-854.DOI:10.1016/0092-8674(93)90529-y. Cited in this article [1]

[5]	Lagos-Quintana M, Rauhut R, Lendeckel W, et al. Identification of novel genes coding for small expressed RNAs[J]. Science, 2001, 294(5543):853-858.DOI:10.1126/science.1064921. Cited in this article [1]

[6]	Seyhan AA. Circulating microRNAs as potential biomarkers in pancreatic cancer-advances and challenges[J]. Int J Mol Sci, 2023, 24(17):13340.DOI:10.3390/ijms241713340. Cited in this article [1]

[7]	Lewis BP, Burge CB, Bartel DP. Conserved seed pairing,often flanked by adenosines,indicates that thousands of human genes are microRNA targets[J]. Cell, 2005, 120(1):15-20.DOI:10.1016/j.cell.2004.12.035. Cited in this article [1]

[8]	Chen G, Hu J, Huang Z, et al. MicroRNA-1976 functions as a tumor suppressor and serves as a prognostic indicator in non-small cell lung cancer by directly targeting PLCE1[J]. Biochem Biophys Res Commun, 2016, 473(4):1144-1151.DOI:10.1016/j.bbrc.2016.04.030. Cited in this article [2]

[9]	Matthews HK, Bertoli C, de Bruin RAM. Cell cycle control in cancer[J]. Nat Rev Mol Cell Biol, 2022, 23(1):74-88.DOI:10.1038/s41580-021-00404-3.

[10]	Calin GA, Sevignani C, Dumitru CD, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers[J]. Proc Natl Acad Sci U S A, 2004, 101(9):2999-3004.DOI:10.1073/pnas.0307323101. Cited in this article [1]

[11]	Wang J, Li M, Han X, et al. MiR-1976 knockdown promotes epithelial-mesenchymal transition and cancer stem cell properties inducing triple-negative breast cancer metastasis[J]. Cell Death Dis, 2020, 11(7):500.DOI:10.1038/s41419-020-2711-x. Cited in this article [2]

[12]	Shi Q, Xu G, Jiang Y, et al. Phospholipase PLCE1 promotes transcription and phosphorylation of MCM7 to drive tumor progression in esophageal cancer[J]. Cancer Res, 2024, 84(4):560-576.DOI:10.1158/0008-5472.Can-23-1633. Cited in this article [1]

[13]	Huang P, Zhao H, Sun R, et al. MiR-1976/NCAPH/P65 axis inhibits the malignant phenotypes of lung adenocarcinoma[J]. Sci Rep, 2024, 14(1):11211.DOI:10.1038/s41598-024-61261-6. Cited in this article [1]

[14]	李珊, 张颖辉, 王志芳, 等. LINC00243靶向miR-1976促进甲状腺癌细胞增殖、迁移和侵袭[J]. 现代肿瘤医学, 2021, 29(22):3902-3908.DOI:10.3969/j.issn.1672-4992.2021.22.004. Cited in this article [1]

[15]	Mishra S, Yadav T, Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics[J]. Crit Rev Oncol Hematol, 2016, 98(2):12-23.DOI:10.1016/j.critrevonc.2015.10.003. Cited in this article [1]

[16]	Sahu SS, Dey S, Nabinger SC, et al. The role and therapeutic potential of miRNAs in colorectal liver metastasis[J]. Sci Rep, 2019, 9(1):15803.DOI:10.1038/s41598-019-52225-2. Cited in this article [1]

[17]	Latchana N, Abrams ZB, Howard JH, et al. Plasma microRNA levels following resection of metastatic melanoma[J]. Bioinform Biol Insights, 2017,11:1177932217694837.DOI:10.1177/1177932217694837. Cited in this article [1]

[18]

Bhadra T, Mallik S, Sohel A, et al. Unsupervised feature selection using an integrated strategy of hierarchical clustering with singular value decomposition:an integrative biomarker discovery method with application to acute myeloid leukemia[J]. IEEE/ACM Trans Comput Biol Bioinform, 2022, 19(3):1354-1364.DOI:10.1109/tcbb.2021.3110989. Cited in this article [1]

[19]	Lee TY, Tseng CJ, Wang JW, et al. Anti-microRNA-1976 as a novel approach to enhance chemosensitivity in XAF1(+) pancreatic and liver cancer[J]. Biomedicines, 2023, 11(4):1136.DOI:10.3390/biomedicines11041136. Cited in this article [2]

[20]	Wang J, Ma G, Han X, et al. The low expression of miR-1976 in plasma samples indicating its biological functions in the progression of breast cancer[J]. Clin Transl Oncol, 2020, 22(11):2111-2120.DOI:10.1007/s12094-020-02361-3. Cited in this article [1]

[21]	Wang Y, Xu M, Yang Q. A six-microRNA signature predicts survival of patients with uterine corpus endometrial carcinoma[J]. Curr Probl Cancer, 2019, 43(2):167-176.DOI:10.1016/j.currproblcancer.2018.02.002. Cited in this article [1]

[22]	Xin G, Cao X, Zhao W, et al. MicroRNA expression profile and TNM staging system predict survival in patients with lung adenocarcinoma[J]. Math Biosci Eng, 2020, 17(6):8074-8083.DOI:10.3934/mbe.2020409. Cited in this article [1]

[23]	Diener C, Keller A, Meese E. Emerging concepts of miRNA therapeutics:from cells to clinic[J]. Trends Genet, 2022, 38(6):613-626.DOI:10.1016/j.tig.2022.02.006. Cited in this article [1]

[24]	Khameneh SC, Razi S, Lashanizadegan R, et al. MicroRNA-mediated metabolic regulation of immune cells in cancer:an updated review[J]. Front Immunol, 2024,15:1424909.DOI:10.3389/fimmu.2024.1424909. Cited in this article [1]

[25]	D’Arpa P, Beardmore C, Liu LF. Involvement of nucleic acid synthesis in cell killing mechanisms of topoisomerase poisons[J]. Cancer Res, 1990, 50(21):6919-6924. Cited in this article [3]

[26]	Vaxevanis C, Bachmann M, Seliger B. Immune modulatory microRNAs in tumors,their clinical relevance in diagnosis and therapy[J]. J Immunother Cancer, 2024, 12(8):e009774.DOI:10.1136/jitc-2024-009774. Cited in this article [2]

[27]	Kim SY, Choi HG, Kim YH, et al. Longitudinal study of the inverse relationship between Parkinson’s disease and cancer in Korea[J]. NPJ Parkinsons Dis, 2023, 9(1):116.DOI:10.1038/s41531-023-00562-5. Cited in this article [1]

[28]	Oh J, Lee HS, Jeon S, et al. Marked reduction in the risk of dementia in patients with breast cancer:a nationwide population-based cohort study[J]. Cancer Res Treat, 2023, 55(2):551-561.DOI:10.4143/crt.2022.272. Cited in this article [1]

[29]	Tacik P, Curry S, Fujioka S, et al. Cancer in Parkinson’s disease[J]. Parkinsonism Relat Disord, 2016, 31(10):28-33.DOI:10.1016/j.parkreldis.2016.06.014. Cited in this article [1]

[30]	Ibáñez K, Boullosa C, Tabarés-Seisdedos R, et al. Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses[J]. PLoS Genet, 2014, 10(2):e1004173.DOI:10.1371/journal.pgen.1004173. Cited in this article [3]

[31]	Li JM, Liu C, Hu X, et al. Inverse correlation between Alzheimer’s disease and cancer:implication for a strong impact of regenerative propensity on neurodegeneration[J]. BMC Neurol, 2014,14:211.DOI:10.1186/s12883-014-0211-2. Cited in this article [1]

[32]	Calegari F, Huttner WB. An inhibition of cyclin-dependent kinases that lengthens,but does not arrest,neuroepithelial cell cycle induces premature neurogenesis[J]. J Cell Sci, 2003, 116(Pt 24):4947-4955.DOI:10.1242/jcs.00825. Cited in this article [1]

[33]	Marlier Q, D’Aes T, Verteneuil S, et al. Core cell cycle machinery is crucially involved in both life and death of post-mitotic neurons[J]. Cell Mol Life Sci, 2020, 77(22):4553-4571.DOI:10.1007/s00018-020-03548-1. Cited in this article [3]

[34]	Kurita M, Kuwajima T, Nishimura I, et al. Necdin downregulates CDC2 expression to attenuate neuronal apoptosis[J]. J Neurosci, 2006, 26(46):12003-12013.DOI:10.1523/jneurosci.3002-06.2006. Cited in this article [1]

[35]	侯一玮, 王洪财, 葛汝丽. 细胞周期G2/M期调控与神经变性疾病[J]. 国际神经病学神经外科学杂志, 2018, 45(3):320-323.DOI:10.16636/j.cnki.jinn.2018.03.024. Cited in this article [1]

[36]	Vincent I, Jicha G, Rosado M, et al. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer’s disease brain[J]. J Neurosci, 1997, 17(10):3588-3598.DOI:10.1523/jneurosci.17-10-03588.1997. Cited in this article [1]

[37]	Paccosi E, Proietti-De-Santis L. Parkinson’s disease:from genetics and epigenetics to treatment,a miRNA-based strategy[J]. Int J Mol Sci, 2023, 24(11):9547.DOI:10.3390/ijms24119547. Cited in this article [1]

[38]	邱峰, 吴越, 曹辉, 等. 帕金森病异常表达microRNAs的筛选及microRNA-1976作用机制的初步研究[J]. 临床神经病学杂志, 2017, 30(3):171-174. Cited in this article [1]

[39]	Qiu F, Wu Y, Xie G, et al. MiRNA-1976 regulates the apoptosis of dopaminergic neurons by targeting the PINK1 gene[J]. J Integr Neurosci, 2023, 22(2):45.DOI:10.31083/j.jin2202045. Cited in this article [2]

[40]	Desideri E, Martins LM. Mitochondrial stress signalling:HTAR2 and Parkinson’s disease[J]. Int J Cell Biol, 2012,2012:607929.DOI:10.1155/2012/607929. Cited in this article [1]

[41]	Pickles S, Vigié P, Youle RJ. Mitophagy and quality control mechanisms in mitochondrial maintenance[J]. Curr Biol, 2018, 28(4):R170-R185.DOI:10.1016/j.cub.2018.01.004. Cited in this article [1]

[42]	O’Flanagan CH, Morais VA, Wurst W, et al. The Parkinson’s gene PINK1 regulates cell cycle progression and promotes cancer-associated phenotypes[J]. Oncogene, 2015, 34(11):1363-1374.DOI:10.1038/onc.2014.81. Cited in this article [1]

[43]	谢涛波, 钟纯正, 符尧天. miR-1976在帕金森综合征中的作用[J]. 临床和实验医学杂志, 2018, 17(13):1378-1381.DOI:10.3969/j.issn.1671-4695.2018.13.010. Cited in this article [1]

[44]	Han B, Chen Y, Song C, et al. Autophagy modulates the stability of Wee1 and cell cycle G2/M transition[J]. Biochem Biophys Res Commun, 2023, 677(40):63-69.DOI:10.1016/j.bbrc.2023.08.010. Cited in this article [1]

[45]	Ghelli Luserna di Rorà A, Cerchione C, Martinelli G, et al. A,Cerchione C,Martinelli G,et al.A WEE1 family business:regulation of mitosis,cancer progression,and therapeutic target[J]. J Hematol Oncol, 2020, 13(1):126.DOI:10.1186/s13045-020-00959-2. Cited in this article [1]

[46]	陈婷, 陈浩, 师亮, 等. 微小RNA-124和RNA-1976在帕金森病患者血清中的表达及临床价值[J]. 中华老年医学杂志, 2024, 43(1):23-28.DOI:10.3760/cma.j.issn.0254-9026.2024.01.005. Cited in this article [1]

[47]	欧诒丹, 钟纯正, 高元杰, 等. 帕金森病患者血清miR-1976、GDF-15水平变化及与姿势步态异常型的关系[J]. 中风与神经疾病杂志, 2023, 40(5):406-410.DOI:10.19845/j.cnki.zfysjjbzz.2023.0096. Cited in this article [1]

[48]	Liu DZ, Ander BP, Sharp FR. Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases[J]. Neurobiol Dis, 2010, 37(3):549-557.DOI:10.1016/j.nbd.2009.11.013. Cited in this article [1]

[49]	Pekarek L, Torres-Carranza D, Fraile-Martinez O, et al. An overview of the role of microRNAs on carcinogenesis:a focus on cell cycle,angiogenesis and metastasis[J]. Int J Mol Sci, 2023, 24(8):7268.DOI:10.3390/ijms24087268. Cited in this article [1]

[50]	Zhai P, Tong T, Wang X, et al. Nuclear miR-451a activates KDM7A and leads to cetuximab resistance in head and neck squamous cell carcinoma[J]. Cell Mol Life Sci, 2024, 81(1):282.DOI:10.1007/s00018-024-05324-x. Cited in this article [1]

[51]	Qiu X, Danesh Yazdi M, Wang C, et al. Extracellular microRNAs associated with psychiatric symptoms in the Normative Aging Study[J]. J Psychiatr Res, 2024, 178(10):270-277.DOI:10.1016/j.jpsychires.2024.08.017. Cited in this article [1]

[52]	俞雯雯, 张航, 葛卫红, 等. β-榄香烯诱导人脑胶质瘤U251细胞凋亡的机制研究[J]. 浙江中医药大学学报, 2014, 38(4):451-455,460.DOI:10.16466/j.issn1005-5509.2014.04.021. Cited in this article [1]